Insider at

04

Insider transactions

05
0 buys (P) 5 sells (S) Net: $-4,173,581 + 31 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

31 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 3, 2026 TEVA S 10b5-1 25,578 $34.88 $892,161 134,877 Direct -15.94% Disposed 13.7% (price as of 2026-10-05)
March 5, 2026 TEVA S 10b5-1 9,533 $31.67 $301,910 107,711 Direct -8.13% Disposed 25.2% (price as of 2026-10-05)
March 4, 2026 TEVA S 10b5-1 11,277 $32.46 $366,051 97,590 Direct -10.36% Disposed 22.2% (price as of 2026-10-05)
March 3, 2026 TEVA S 10b5-1 68,685 $32.36 $2,222,647 85,616 Direct -44.51% Disposed 22.5% (price as of 2026-10-05)
March 3, 2026 TEVA S 10b5-1 12,077 $32.36 $390,812 12,823 Direct -48.50% Disposed 22.5% (price as of 2026-10-05)
Aug. 1, 2025 TEVA S 10b5-1 52,742 $15.16 $799,569 0 Direct -100.00% Disposed 161.5% (price as of 2026-10-05)
March 5, 2025 TEVA S 10b5-1 8,077 $15.91 $128,505 0 Direct -100.00% Disposed 149.2% (price as of 2026-10-05)
March 4, 2025 TEVA S 10b5-1 15,174 $15.73 $238,687 8,077 Direct -65.26% Disposed 152.1% (price as of 2026-10-05)
March 4, 2025 TEVA S 10b5-1 5,174 $15.56 $80,507 0 Direct -100.00% Disposed 154.8% (price as of 2026-10-05)
March 3, 2025 TEVA S 10b5-1 19,726 $16.19 $319,364 5,174 Direct -79.22% Disposed 144.9% (price as of 2026-10-05)
Aug. 9, 2024 TEVA S 45,060 $17.38 $783,143 0 Direct -100.00% Disposed 128.1% (price as of 2026-10-05)
Aug. 1, 2024 TEVA S 10b5-1 24,537 $17.25 $423,263 45,060 Direct -35.26% Disposed 129.9% (price as of 2026-10-05)
March 4, 2024 TEVA S 10b5-1 8,045 $13.34 $107,320 16,855 Direct -32.31% Disposed 197.2% (price as of 2026-10-05)
Aug. 1, 2023 TEVA S 10b5-1 52,742 $8.30 $437,759 0 Direct -100.00% Disposed 377.7% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Aug. 3, 2026 TEVA Restricted Share Units Ordinary Shares [F1] (52,744) · · 52,744 Disposed
June 11, 2026 GLUE Stock Option (Right to Buy) Common Stock (25,800) $17.10 June 11, 2036 25,800 Acquired
March 5, 2026 TEVA Restricted Share Units Ordinary Shares [F1] (19,654) · · 19,654 Disposed
March 4, 2026 TEVA Restricted Share Units Ordinary Shares [F1] (50,643) · · 50,643 Acquired
March 4, 2026 TEVA Restricted Share Units Ordinary Shares [F1] (23,251) · · 23,251 Disposed
March 3, 2026 TEVA Restricted Share Units Ordinary Shares [F1] (141,478) · · 141,478 Disposed
March 3, 2026 TEVA Restricted Share Units Ordinary Shares [F1] (24,900) · · 24,900 Disposed
Jan. 27, 2026 TEVA Restricted Share Units Ordinary Shares [F3] (141,478) · · 141,478 Acquired
Aug. 1, 2025 TEVA Restricted Share Units Ordinary Shares [F1] (52,742) · · 52,742 Disposed
June 13, 2025 GLUE Stock Option (Right to Buy) Common Stock (30,700) $4.91 June 13, 2035 30,700 Acquired
March 5, 2025 TEVA Restricted Share Units Ordinary Shares [F3] (78,616) · · 78,616 Acquired
March 4, 2025 TEVA Restricted Share Units Ordinary Shares [F1] (0) · · 23,251 Disposed
March 3, 2025 TEVA Restricted Share Units Ordinary Shares [F1] (24,900) · · 24,900 Disposed
Dec. 11, 2024 GLUE Stock Option (Right to Buy) Common Stock (44,200) $8.51 Dec. 10, 2034 44,200 Acquired
Aug. 1, 2024 TEVA Restricted Share Units Ordinary Shares [F1] (52,742) · · 52,742 Disposed
March 4, 2024 TEVA Restricted Share Units Ordinary Shares [F1] (93,005) · · 93,005 Acquired
March 3, 2024 TEVA Restricted Share Units Ordinary Shares [F1] (24,900) · · 24,900 Disposed
Aug. 1, 2023 TEVA Restricted Share Units Ordinary Shares [F1] (52,742) · · 52,742 Disposed
March 3, 2023 TEVA Restricted Share Units Ordinary Shares [F3] (99,601) · · 99,601 Acquired
Aug. 1, 2022 TEVA Restricted Share Units Ordinary Shares [F3] (210,970) · · 210,970 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

TEVA

Global R&D and Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $829,231 · · · $1,569,817 · $149,902 $6,298,933
2024 $753,846 · · · $1,116,748 · $134,218 $5,754,787

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.